Methylene diphosphonate

Methylene diphosphonate (MDP or medronic acid) is a pharmaceutical product used especially in nuclear medicine, linked to 99mTc, as a marker to avoid the Single Photon Emission Scintigraphy, or SPECT, to localize carcinogentic bone metastasis as well as other diseases that can alter the natural turn-over in bone.